Financials

News Ideas Discussions Technicals Seasonals

MOB fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Moberg Pharma AB is a pharmaceutical company, which engages in the development and commercialization of medical products. Its product pipeline includes MOB-015, which is a treatment for nail fungus. The company was founded by Peter Gunnar Maurits Wolpert and Marie Moberg in March 2006 and is headquartered in Bromma, Sweden.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

MOB has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company